Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that […]
Sound Group Inc. Announces Trading under New Name on Nasdaq
SINGAPORE, Jan. 26, 2024 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global audio-centric […]
Southside Bancshares, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023
Fourth quarter net income of $17.3 million; Linked quarter loan growth of 2.3%; Fourth quarter earnings per diluted common share […]
CNH to release 2023 Fourth Quarter & Full Year financial results on February 14
CNH to release 2023 Fourth Quarter & Full Year financial results on February 14 Basildon, January 26, 2024 CNH (NYSE: […]
Stearman Miniac Property Update
VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) — Stearman Resources Inc. (CSE:STMN) (“Stearman” or the “Company”) is focused on […]
TSX News -
Québec Superior Court suspends provisions of Bill 21
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES […]
YanGuFang Announces Receipt of Nasdaq Notice of Deficiency Resulting from Resignation of Director
SHANGHAI, China, Jan. 25, 2024 (GLOBE NEWSWIRE) — YanGuFang International Group Co., Ltd. (Nasdaq: YGF) (“YanGuFang” or the “Company”), a […]
TSX News -
HEALWELL AI to Acquire Intrahealth to Create Next Generation AI Powered EHR
HEALWELL enters into agreement to acquire Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider supporting approximately […]
Kayne Anderson Energy Infrastructure Fund Files 2023 Annual Report
HOUSTON, Jan. 25, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today that […]
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
SAN MATEO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing […]
